As of 2026-01-24, the EV/EBITDA ratio of WAVE Life Sciences Ltd (WVE) is -15.93. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WVE's latest enterprise value is 2,055.70 mil USD. WVE's TTM EBITDA according to its financial statements is -129.03 mil USD. Dividing these 2 quantities gives us the above WVE EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 0.9x - 9.3x | 1.1x |
| Forward P/E multiples | 0.9x - 9.3x | 1.1x |
| Fair Price | 0.49 - (6.00) | 0.32 |
| Upside | -96.3% - -144.6% | -97.6% |
| Date | EV/EBITDA |
| 2026-01-16 | -16.17 |
| 2026-01-15 | -16.71 |
| 2026-01-14 | -17.28 |
| 2026-01-13 | -16.90 |
| 2026-01-12 | -16.50 |
| 2026-01-09 | -16.41 |
| 2026-01-08 | -17.69 |
| 2026-01-07 | -18.47 |
| 2026-01-06 | -18.11 |
| 2026-01-05 | -17.91 |
| 2026-01-02 | -19.15 |
| 2025-12-31 | -20.51 |
| 2025-12-30 | -20.70 |
| 2025-12-29 | -21.62 |
| 2025-12-26 | -21.50 |
| 2025-12-24 | -22.13 |
| 2025-12-23 | -21.13 |
| 2025-12-22 | -21.76 |
| 2025-12-19 | -19.18 |
| 2025-12-18 | -18.61 |
| 2025-12-17 | -19.65 |
| 2025-12-16 | -19.74 |
| 2025-12-15 | -19.35 |
| 2025-12-12 | -19.94 |
| 2025-12-11 | -20.18 |
| 2025-12-10 | -24.69 |
| 2025-12-09 | -26.09 |
| 2025-12-08 | -22.48 |
| 2025-12-05 | -8.18 |
| 2025-12-04 | -8.35 |
| 2025-12-03 | -7.73 |
| 2025-12-02 | -7.54 |
| 2025-12-01 | -8.08 |
| 2025-11-28 | -8.53 |
| 2025-11-26 | -8.42 |
| 2025-11-25 | -8.11 |
| 2025-11-24 | -8.14 |
| 2025-11-21 | -7.61 |
| 2025-11-20 | -7.23 |
| 2025-11-19 | -7.39 |
| 2025-11-18 | -7.69 |
| 2025-11-17 | -7.74 |
| 2025-11-14 | -7.65 |
| 2025-11-13 | -7.12 |
| 2025-11-12 | -7.49 |
| 2025-11-11 | -7.89 |
| 2025-11-10 | -7.61 |
| 2025-11-07 | -8.66 |
| 2025-11-06 | -8.69 |
| 2025-11-05 | -8.90 |